Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 1
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for melinda fries
Your search for Melinda Friesz retrieved no results
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.
Madhi SA, Polack FP, Piedra PA, Munoz FM, Trenholme AA, Simões EAF, Swamy GK, Agrawal S, Ahmed K, August A, Baqui AH, Calvert A, Chen J, Cho I, Cotton MF, Cutland CL, Englund JA, Fix A, Gonik B, Hammitt L, Heath PT, de Jesus JN, Jones CE, Khalil A, Kimberlin DW, Libster R, Llapur CJ, Lucero M, Pérez Marc G, Marshall HS, Masenya MS, Martinón-Torres F, Meece JK, Nolan TM, Osman A, Perrett KP, Plested JS, Richmond PC, Snape MD, Shakib JH, Shinde V, Stoney T, Thomas DN, Tita AT, Varner MW, Vatish M, Vrbicky K, Wen J, Zaman K, Zar HJ, Glenn GM, Fries LF; Prepare Study Group. Madhi SA, et al. N Engl J Med. 2020 Jul 30;383(5):426-439. doi: 10.1056/NEJMoa1908380. N Engl J Med. 2020. PMID: 32726529 Free PMC article. Clinical Trial.
The suggestion of a possible benefit with respect to other end-point events involving RSV-associated respiratory disease in infants warrants further study. (Funded by Novavax and the Bill and Melinda Gates Foundation; ClinicalTrials.gov NCT02624947.)....
The suggestion of a possible benefit with respect to other end-point events involving RSV-associated respiratory disease in infants warrants …
Hierarchical design of pseudosymmetric protein nanoparticles.
Dowling QM, Park YJ, Gerstenmaier N, Yang EC, Wargacki A, Hsia Y, Fries CN, Ravichandran R, Walkey C, Burrell A, Veesler D, Baker D, King NP. Dowling QM, et al. bioRxiv [Preprint]. 2023 Jun 17:2023.06.16.545393. doi: 10.1101/2023.06.16.545393. bioRxiv. 2023. PMID: 37398374 Free PMC article. Preprint.
Hierarchical design of pseudosymmetric protein nanoparticles.
Dowling QM, Park YJ, Gerstenmaier N, Yang EC, Wargacki A, Hsia Y, Fries CN, Ravichandran R, Walkey C, Burrell A, Veesler D, Baker D, King NP. Dowling QM, et al. Res Sq [Preprint]. 2023 Jul 10:rs.3.rs-3074553. doi: 10.21203/rs.3.rs-3074553/v1. Res Sq. 2023. PMID: 37503272 Free PMC article. Preprint.
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
Shinde V, Bhikha S, Hoosain Z, Archary M, Bhorat Q, Fairlie L, Lalloo U, Masilela MSL, Moodley D, Hanley S, Fouche L, Louw C, Tameris M, Singh N, Goga A, Dheda K, Grobbelaar C, Kruger G, Carrim-Ganey N, Baillie V, de Oliveira T, Lombard Koen A, Lombaard JJ, Mngqibisa R, Bhorat AE, Benadé G, Lalloo N, Pitsi A, Vollgraaff PL, Luabeya A, Esmail A, Petrick FG, Oommen-Jose A, Foulkes S, Ahmed K, Thombrayil A, Fries L, Cloney-Clark S, Zhu M, Bennett C, Albert G, Faust E, Plested JS, Robertson A, Neal S, Cho I, Glenn GM, Dubovsky F, Madhi SA; 2019nCoV-501 Study Group. Shinde V, et al. N Engl J Med. 2021 May 20;384(20):1899-1909. doi: 10.1056/NEJMoa2103055. Epub 2021 May 5. N Engl J Med. 2021. PMID: 33951374 Free PMC article. Clinical Trial.
Most infections were caused by the B.1.351 variant. (Funded by Novavax and the Bill and Melinda Gates Foundation; ClinicalTrials.gov number, NCT04533399.)....
Most infections were caused by the B.1.351 variant. (Funded by Novavax and the Bill and Melinda Gates Foundation; ClinicalTrials.gov …
Supply chains for processed potato and tomato products in the United States will have enhanced resilience with planting adaptation strategies.
Gustafson D, Asseng S, Kruse J, Thoma G, Guan K, Hoogenboom G, Matlock M, McLean M, Parajuli R, Rajagopalan K, Stöckle C, Sulser TB, Tarar L, Wiebe K, Zhao C, Fraisse C, Gimenez C, Intarapapong P, Karimi T, Kruger C, Li Y, Marshall E, Nelson RL, Pronk A, Raymundo R, Riddle AA, Rosenbohm M, Sonke D, van Evert F, Wu G, Xiao L. Gustafson D, et al. Nat Food. 2021 Nov;2(11):862-872. doi: 10.1038/s43016-021-00383-w. Epub 2021 Oct 18. Nat Food. 2021. PMID: 37117500
We find that supply chains for two popular processed products in the United States, French fries and pasta sauce, will be remarkably resilient, through planting adaptation strategies that avoid higher temperatures. ...
We find that supply chains for two popular processed products in the United States, French fries and pasta sauce, will be remarkably …
Sweetpotato cultivation: characteristics, constraints and preferred traits of producers and consumers in Côte d'Ivoire.
Kouassi JHM, Dibi KEB, Boye MA, Essis BS, Kouakou AM, N'zué B, Dufour D. Kouassi JHM, et al. J Sci Food Agric. 2024 Jun;104(8):4922-4929. doi: 10.1002/jsfa.12923. Epub 2023 Oct 17. J Sci Food Agric. 2024. PMID: 37574585
The main food products or forms of preparation from roots are fries (34.7%), boiled (34.3%), mashed (12.4%), and sweetpotato stew (9.1%). ...
The main food products or forms of preparation from roots are fries (34.7%), boiled (34.3%), mashed (12.4%), and sweetpotato stew (9. …
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial.
Madhi SA, Moodley D, Hanley S, Archary M, Hoosain Z, Lalloo U, Louw C, Fairlie L, Fouche LF, Masilela MSL, Singh N, Grobbelaar C, Ahmed K, Benadé G, Bhikha S, Bhorat AE, Bhorat Q, Joseph N, Dheda K, Esmail A, Foulkes S, Goga A, Oommen Jose A, Kruger G, Kalonji DJ, Lalloo N, Lombaard JJ, Lombard Koen A, Kany Luabeya A, Mngqibisa R, Petrick FG, Pitsi A, Tameris M, Thombrayil A, Vollgraaff PL, Cloney-Clark S, Zhu M, Bennett C, Albert G, Faust E, Plested JS, Fries L, Robertson A, Neal S, Cho I, Glenn GM, Shinde V; 2019nCoV-501 Study Group. Madhi SA, et al. Lancet HIV. 2022 May;9(5):e309-e322. doi: 10.1016/S2352-3018(22)00041-8. Lancet HIV. 2022. PMID: 35489376 Free PMC article. Clinical Trial.
However, people living with HIV-1 not previously exposed to SARS-CoV-2 had attenuated humoral immune responses to NVX-CoV2373 compared with their HIV-negative vaccine counterparts, but not so if they were baseline SARS-CoV-2-positive. FUNDING: Novavax and the Bill & Melind …
However, people living with HIV-1 not previously exposed to SARS-CoV-2 had attenuated humoral immune responses to NVX-CoV2373 compared with …